🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Erlotinib may stop the growth of tumor cells by blocking the enzymes necess...
Status
Terminated
Location
University of Chicago Comprehensive Cancer Center
Start Date
2002-05
Trial ID
NCT00042835
Cisplatin or Carboplatin will be given on day 1 every 21 days for 6 cycles;...
Status
Completed
Location
Princess Margaret Hospital
Start Date
2006-06
Trial ID
NCT00603915
Treatments Being Tested
This is a Phase II open study, not randomized with a neoadjuvant therapy,co...
Status
Completed
Location
Clínica Universitaria de Navarra
Start Date
2011-05
Trial ID
NCT01389440
Treatments Being Tested
GATE 1 is an open-label, non-comparative, multicentric study evaluating the...
Status
Completed
Location
Centre Val d'Aurelle
Start Date
2010-06
Trial ID
NCT01204372
Treatments Being Tested
This study aims to assess the value of combined treatment with RAD001 and e...
Status
Completed
Location
Novartis Investigative Site
Start Date
2005-06
Trial ID
NCT00456833
Chronic Hepatitis C Virus (HCV) infection is a major cause of liver cirrhos...
Status
Unknown
Location
Service d'Hépatogastroentérologie, NHC1, place de l'hôpital
Start Date
2013-05
Trial ID
NCT01835938
Treatments Being Tested
This phase I trial is studying the side effects and best dose of erlotinib ...
Status
Completed
Location
Vanderbilt-Ingram Cancer Center
Start Date
2007-01
Trial ID
NCT00397384
Treatments Being Tested
This is an open label, non-randomized, sequential, phase I/II trial in pati...
Status
Terminated
Location
Hospital de la Santa Creu i Sant Pau
Start Date
2008-05
Trial ID
NCT00503971
Treatments Being Tested
This phase I trial is studying the side effects and best dose of erlotinib ...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2003-05
Trial ID
NCT00063947
Phase II Study of Maintenance Tarceva (Erlotinib) in patients with locally ...
Status
Terminated
Location
Geisinger Health System
Start Date
2008-09
Trial ID
NCT00750555
Treatments Being Tested